Abstract

Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding

Author(s): Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel

Issue: Jul/Aug 2009 - Homone Replacement Therapy

Page(s): 314-317

Download in electronic PDF format for $75
  • Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Page 1
  • Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Page 2
  • Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Page 3
  • Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Page 4

Abstract

This article is an adaptation of an abstract/poster presentation made at the 13th Annual International Congress on Steroidal Hormones and Hormones & Cancer, Quebec City, Canada (September 2008), concerning the topic of breast feeding as a contraindication to testosterone therapy. The purpose of the presentation and this article is to provide a summary of the findings of a study that was conducted to evaluate maternal absorption of testosterone and its excretion into breast milk by using three methods of delivery: sublingual drops, vaginal cream, and pellet implant. Testosterone was measurable in maternal blood by all three methods of delivery. No significant increase of testosterone was seen in breast milk when testosterone was delivered by vaginal cream, sublingual drops, of subcutaneous pellet implant. Testosterone was very low in infant blood at baseline and during testosterone therapy by pellet implant. There were no adverse clinical effects in the infant after seven months of continuous testosterone ther

Related Keywords

  • breast feeding
  • infants
  • androgen deficiency
  • testosterone
  • breast milk
  • route of administration
  • hormone replacement therapy
  • HRT
  • pellet implant
  • sublingual drops
  • vaginal cream
  • capillary bloodspot
  • estradiol
  • absorption

Related Categories

  • HRT
  • PEDIATRICS
  • ADVERSE DRUG EVENTS
  • DOSAGE FORMS/DRUG CARRIERS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • PATIENT ASSESSMENT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2009
Pg. 314-317
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Author(s): Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2011
Pg. 290-300
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Author(s): Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Jul/Aug 2005
Pg. 259-264
View Sample
Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
Author(s): Tan Robert S
Jan/Feb 2001
Pg. 52-54
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Author(s): Ford Gina, Garcia Lea
Jul/Aug 2003
Pg. 250-256
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Author(s): Gillson George R, Zava David T
Jan/Feb 2004
Pg. 16-21
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Author(s): Cutter Christopher B
Sep/Oct 2023
Pg. 358-360
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Author(s): Biundo Bruce
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J
May/Jun 2018
Pg. 190-195
Establishing a Rationale for Compounding Hormone Replacement Therapy
Author(s): Biundo Bruce
Jan/Feb 2024
Pg. 22-27
Establishing a Rationale for Compounding Hormone Replacement Therapy
Author(s): Biundo Bruce
Jul/Aug 2002
Pg. 250-254
The Hormonal Link to Breast Cancer: The Estrogen Matrix
Author(s): Zava David T
Nov/Dec 2016
Pg. 447-454
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Author(s): Deleruyelle Laura J
Jan/Feb 1999
Pg. 34-35
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Author(s): Mason Dave
Mar/Apr 2002
Pg. 142-146
Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Author(s): Wepfer Scott T
Mar/Apr 2010
Pg. 94-99
Emerging Evidence for Androgen Replacement Therapy in Aging Men
Author(s): Bramwell Bethany L
Jul/Aug 2010
Pg. 276-282
Recommendations for Compounding Medications for Feeding Tube Administration
Author(s): Klang Mark
Mar/Apr 2012
Pg. 110-114
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Author(s): Griffee Chris, Delano Amy
Jul/Aug 2019
Pg. 325-339
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Author(s): Glaser Rebecca L, York Anne E
Jan/Feb 2015
Pg. 6-12
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2011
Pg. 102-112
Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Author(s): Kells John, DollbaumCharles M